Cargando…

Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report

BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeyama, Eriko, Wada, Aiko, Amano, Eizo, Shibuya, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967279/
https://www.ncbi.nlm.nih.gov/pubmed/32025915
http://dx.doi.org/10.1186/s40981-018-0222-x
_version_ 1783488920005115904
author Takeyama, Eriko
Wada, Aiko
Amano, Eizo
Shibuya, Hiromi
author_facet Takeyama, Eriko
Wada, Aiko
Amano, Eizo
Shibuya, Hiromi
author_sort Takeyama, Eriko
collection PubMed
description BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the appropriate time to resume antiplatelet therapy is unclear. CASE PRESENTATION: A 75-year-old woman (height 134 cm, weight 37 kg) underwent flow diverter embolization for unruptured cerebral aneurysm under general anaesthesia. The patient received dual antiplatelet therapy before surgery and anticoagulation therapy intraoperatively. After surgery, the patient developed hematemesis and was diagnosed with oesophageal submucosal hematoma. Conservative treatment was initiated after discontinuing antiplatelet therapy, which was resumed 3 days after surgery. The patient showed good recovery even after the resumption of antiplatelet therapy. CONCLUSIONS: In our case, we successfully treated oesophageal submucosal hematoma developing after endovascular surgery with early resumption of postoperative antiplatelet therapy.
format Online
Article
Text
id pubmed-6967279
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69672792020-02-04 Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report Takeyama, Eriko Wada, Aiko Amano, Eizo Shibuya, Hiromi JA Clin Rep Case Report BACKGROUND: Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial. If antiplatelet therapy is discontinued, the appropriate time to resume antiplatelet therapy is unclear. CASE PRESENTATION: A 75-year-old woman (height 134 cm, weight 37 kg) underwent flow diverter embolization for unruptured cerebral aneurysm under general anaesthesia. The patient received dual antiplatelet therapy before surgery and anticoagulation therapy intraoperatively. After surgery, the patient developed hematemesis and was diagnosed with oesophageal submucosal hematoma. Conservative treatment was initiated after discontinuing antiplatelet therapy, which was resumed 3 days after surgery. The patient showed good recovery even after the resumption of antiplatelet therapy. CONCLUSIONS: In our case, we successfully treated oesophageal submucosal hematoma developing after endovascular surgery with early resumption of postoperative antiplatelet therapy. Springer Berlin Heidelberg 2019-01-08 /pmc/articles/PMC6967279/ /pubmed/32025915 http://dx.doi.org/10.1186/s40981-018-0222-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Takeyama, Eriko
Wada, Aiko
Amano, Eizo
Shibuya, Hiromi
Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title_full Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title_fullStr Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title_full_unstemmed Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title_short Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
title_sort oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967279/
https://www.ncbi.nlm.nih.gov/pubmed/32025915
http://dx.doi.org/10.1186/s40981-018-0222-x
work_keys_str_mv AT takeyamaeriko oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport
AT wadaaiko oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport
AT amanoeizo oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport
AT shibuyahiromi oesophagealsubmucosalhematomaafterflowdiverterembolizationwithfavourableoutcometreatedbydiscontinuingpostoperativeantiplatelettherapyforonlythreedaysacasereport